Cue Biopharma Inc
(CUE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 2,658 | 1,717 | 1,821 | 2,100 | 1,382 |
| Gross Profit | 2,658 | 1,717 | 1,821 | 2,100 | 1,382 |
| Operating Expenses | 13,041 | 14,385 | 15,654 | 13,519 | 14,899 |
| Operating Income | -10,383 | -12,668 | -13,833 | -11,419 | -13,517 |
| Interest Expense | 215 | 241 | 357 | 286 | 232 |
| Other Income | 427 | 562 | 756 | 700 | 564 |
| Pre-tax Income | -10,171 | -12,347 | -13,434 | -11,005 | -13,185 |
| Net Income Continuous | -10,171 | -12,347 | -13,434 | -11,005 | -13,185 |
| Net Income | $-10,171 | $-12,347 | $-13,434 | $-11,005 | $-13,185 |
| EPS Basic Total Ops | -0.20 | -0.25 | -0.29 | -0.24 | -0.29 |
| EPS Basic Continuous Ops | -0.20 | -0.25 | -0.28 | -0.24 | -0.29 |
| EPS Diluted Total Ops | -0.20 | -0.25 | -0.29 | -0.24 | -0.29 |
| EPS Diluted Continuous Ops | -0.20 | -0.25 | -0.28 | -0.24 | -0.29 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.25 | -0.28 | N/A | N/A |
| EBITDA(a) | $-10,275 | $-12,560 | $-13,711 | $-11,291 | $-13,445 |